Mayo Clinic: World-class researchers and physicians, 'exceptional' Cancer Center

Volume 3, Issue 2, 2014

Summary

The National Cancer Institute has renewed the Mayo Clinic Cancer Center's support grant.

Photograph of Robert B. Diasio, M.D., director, Mayo Clinic Cancer Center

Robert B. Diasio, M.D.

It is my pleasure to share the news that the Mayo Clinic Cancer Center received an overall "exceptional" score on the competitive renewal of our National Cancer Institute (NCI) Cancer Center support grant.

The grant award will provide funding for the Cancer Center through 2018 and lend essential support to our 10 research programs and 13 shared resources.

Our center's NCI designation as a comprehensive cancer center also was renewed.

To earn the comprehensive cancer center designation, an institution must participate in multidisciplinary laboratory, clinical and population-based research and educate the community it serves about research advances. Of the 41 comprehensive cancer centers in the United States, the Mayo Clinic Cancer Center is the only single center with three geographic sites — Arizona, Florida and Minnesota.

Exceptional is the NCI's highest cancer center rating. This rating reflects the level of science being conducted by our researchers and the high quality of our staff. Less than 10 percent of NCI-designated cancer centers receive exceptional scores.

I am extremely proud of the work we do in the Mayo Clinic Cancer Center every day. The NCI's renewal of our support grant is an affirmation of the role the Cancer Center plays in reducing the burden of cancer on patients and their loved ones.

I invite you to read this issue of Forefront to learn what we're doing next.

Robert B. Diasio, M.D.
Director, Mayo Clinic Cancer Center
William J. and Charles H. Mayo Professor